Md24 Oc, Inc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Plaza Tower I 600 Anton Blvd,, Suite 1100,, Costa Mesa, AZ 92626 Phone: 623-374-7774 |
News Archive
MyoKardia, Inc., a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable cardiovascular diseases, today announced the publication of an article in the leading medical journal Science.
Cancer is the leading cause of death among people with diabetes in England. This is the finding of an 18-year-study of over 300,000 people with diabetes in England, from scientists from Imperial College London and published in the journal The Lancet Diabetes & Endocrinology.
Blood pressure reduction per se, rather than the particular antihypertensive used, reduces the risk for cardiovascular events in patients with chronic kidney disease, shows a meta-analysis published in BMJ.
Scientific research usually takes months to be published by academic journals, and once it is, many of the papers can only be read by scientists from wealthy institutes that subscribe to the journals.
The Westaim Corporation announced that it has completed the second and final tranche of its private placement of subscription receipts (Subscription Receipts) with the sale today of 3,255,000 Subscription Receipts at a purchase price of $0.50 each for gross proceeds of $1,627,500 bringing the aggregate gross proceeds of the Subscription Receipt financing to $275,000,000. The terms of the Subscription Receipts and details regarding the initial tranche can be found in the Company's press release dated February 9, 2010.
› Verified 7 days ago